Gene: DMBX1
Official Full Name: diencephalon/mesencephalon homeobox 1provided by HGNC
Gene Summary: This gene encodes a member of the bicoid sub-family of homeodomain-containing transcription factors. The encoded protein acts as a transcription factor and may play a role in brain and sensory organ development. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27078 | DMBX1 Knockout cell line (HeLa) | Human | DMBX1 | 1:3~1:6 | Negative | Online Inquiry |
KO27079 | DMBX1 Knockout cell line (HCT 116) | Human | DMBX1 | 1:2~1:4 | Negative | Online Inquiry |
KO27080 | DMBX1 Knockout cell line (HEK293) | Human | DMBX1 | 1:3~1:6 | Negative | Online Inquiry |
DMBX1 Gene Knockout Cell Lines represent a sophisticated tool for research focused on understanding the biological functions and regulatory mechanisms of the DMBX1 gene. This gene, implicated in various developmental processes and biological pathways, plays a pivotal role in defining cellular responses and functions. The DMBX1 Gene Knockout Cell Lines are engineered through CRISPR-Cas9 technology, facilitating the specific deletion of the DMBX1 gene, resulting in a cell model that closely mimics the physiological conditions observed in gene loss-of-function scenarios.
The primary function of these knockout cell lines lies in their ability to provide insights into the cellular impact of DMBX1 deletion. By studying the changes in gene expression, protein activity, and cellular phenotype, researchers can elucidate the downstream effects of DMBX1 loss, including implications for diseases such as cancer or metabolic disorders. Moreover, the knockout model is instrumental in validating potential therapeutic targets, enabling high-throughput drug screening and leading to the development of novel intervention strategies.
Scientifically, the importance of DMBX1 Gene Knockout Cell Lines cannot be overstated. They serve as a critical resource for academic and pharmaceutical research, allowing for a deeper understanding of gene function in health and disease. Compared to conventional knockdown approaches, our gene knockout technology offers higher specificity and permanency in gene disruption, reducing variability and enhancing reproducibility in experimental results.
For researchers and clinicians, the DMBX1 Gene Knockout Cell Lines stand out due to their versatility and compatibility with various assays, including functional analyses, imaging studies, and gene expression profiling. With our commitment to quality assurance and scientific rigor, our company's expertise in cellular models ensures that these cell lines not only meet but exceed the benchmarks established in cutting-edge biological research. Choosing our DMBX1 Gene Knockout Cell Lines empowers researchers with the tools needed to advance their understanding of complex biological systems and develop targeted therapeutic strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.